Results: The percentage of patients with increased levels ofIL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, VEGF, IFN-γ and TNF-α were 40.8%, 48.7%, 32.9%, 52.6%, 100%, 39.5%, 81.6%, 51.3%, 67.1% and 61.8%; respectively.